NEW YORK, June 17, 2024 /PRNewswire/ — UBPet, a smart home appliance brand with a focus on design and development in the field of smart pet AI products, is excited to announce the launch of its latest innovation, the UBPet V10 robot vacuum cleaner. The product, now available on Amazon in the United States, emerges […]
Category Archives: Pr Newswire
QINGDAO, China, June 17, 2024 /PRNewswire/ — Hisense, a global home appliance and consumer electronics brand, is currently making its third appearance at the UEFA European Championship™. As the UEFA EURO 2024™ Official Screen Provider for the Video-Assisted Referee (VAR), Hisense is exhibiting its dedication to technological progress whilst also highlighting its growing global relevance. […]
17
Jun
Jun
— Publication shows treatment demonstrated durable response rate of 48.4% vs. 0% with placebo — — Presentations at EHA showcased subgroup analyses demonstrating consistent benefits regardless of prior lines of therapies or prior TPO/TPO-RA1 exposure — — Data supported regulatory submission in China accepted in January 2024 — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 17, 2024 (GLOBE NEWSWIRE) […]
Please click here for highlight broll footage, video and imagery of Vivid Sydney 2024 SYDNEY, June 17, 2024 /PRNewswire/ — The curtain will close tonight on Vivid Sydney 2024, after an incredible 23 days and nights of Light, Music, Food and Ideas. The lights will go out at 11pm across Vivid Sydney’s festival footprint which has […]
HONG KONG, June 17, 2024 /PRNewswire/ — Football fans are in for a treat as they gear up for UEFA EURO 2024™ with Toshiba TV’s top-performing Gaming TV Z670. As the OFFICIAL TV OF UEFA EURO 2024™, Toshiba TVs present immersive viewing of the football game by their AI-powered TV lineup. To celebrate the brilliant moments […]
HONG KONG, June 17, 2024 /PRNewswire/ — Building on the success of its inaugural edition during Marintec China 2017, Marintec Innovation Conference is back and better than ever! The conference has previously explored a number of fascinating themes, including ‘Cruise Shipbuilding, 2017’, ‘Smart Energy Efficiency Technologies for International Maritime, 2018’, ‘The Fourth Maritime Industrial Revolution, 2020’ […]
Pr Newswire
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
16
Jun
Jun
At 14-months median follow-up in the pivotal trial, 50% of patients achieved a complete response or better and a 71% overall response rate, as presented in an EHA oral presentation and simultaneously published in the Journal of Clinical Oncology Also presented at EHA, a retrospective study of patient outcomes that compared investigational linvoseltamab to real-world […]
Pr Newswire
Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024)
16
Jun
Jun
Objective response rate of 69.2% observed in heavily pretreated patient population including patients with BTK inhibitor resistance mutations Clinical responses in CLL patients were rapid and deepening with longer time on treatment Nurix intends to advance NX-5948 into pivotal trial(s) in 2025 Company will host a webcast conference today, June 16, 2024, at 9:00 a.m. […]
SEOUL, South Korea, June 16, 2024 /PRNewswire/ — In alignment with the global strategic development of Shandong Heavy Industry, with a focus on bolstering “doorstep” export business, from June 14th to 16th, Tan Xuguang led a delegation to South Korea to conduct a thorough market survey. The visit included in-depth assessments of the distribution channels for […]
Pr Newswire
Roche’s Phase III STARGLO study demonstrates Columvi significantly extends survival in people with relapsed or refractory diffuse large B-cell lymphoma
16
Jun
Jun
The study met its primary endpoint of overall survival with a 41% reduction in the risk of death in people with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) treated with Columvi plus chemotherapy1 This Columvi combination could provide a much-needed off-the-shelf treatment option for people with transplant-ineligible R/R DLBCL Data were featured in […]